Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Wisconsin for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Wisconsin only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Wisconsin (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Paul Tuttle (NPI 1023243805)

Field	Value
Entity Type	Individual
Organization	Paul Tuttle
Address	2223 Lime Kiln Rd
City	Green Bay
State	WI
ZIP	54311
Taxonomy	Rheumatology Physician
NPI Enumerated	May 21, 2009

Payer Source	Total Paid
Medicare	$861.3K
Medicaid	$0

Key Findings

This provider’s Medicare billing profile is consistent with a rheumatology practice that delivers in‑office biologic infusions: the top revenue codes are J0129 (abatacept), J1745 (infliximab), and J3262 (tocilizumab), and the claims mix also includes infusion procedure codes such as 96413 (250 claims, $23.8K) and 96365 (188 claims, $8.8K) plus infusion supply J7050 (450 claims, $450). Together these codes point to a service model that combines biologic drug administration with ongoing outpatient management rather than purely clinic visits or diagnostic-only care.

Revenue is highly concentrated in a small number of biologic drug codes: total Medicare revenue is $861.3K and the precomputed top 3 Medicare codes by revenue account for 73.6% of this provider's total Medicare revenue. Those top three codes are J0129 ($266.8K, 30.3%), J1745 ($217.8K, 24.7%), and J3262 ($163.8K, 18.6%), showing dependency on a narrow set of high-cost injectable biologics.

This provider is effectively single‑payer in the available dataset: Medicare accounts for $861.3K of lifetime revenue while there is no Medicaid billing on file. That absence of Medicaid activity indicates payer mix is heavily weighted to Medicare beneficiaries for the public-pay portion of this practice.

Competitive standing on infliximab is relatively strong: J1745 ranks #136 of 1352 providers nationally and is at the 90th percentile, yet the dataset labels its volume as "typical, unremarkable volume." Despite that label, the high national percentile and $217.8K in revenue for J1745 indicate above-peer use of infliximab infusion compared with many rheumatology providers.

By contrast, abatacept and tocilizumab positions are more modest: J0129 ranks #614 of 1221 (50th percentile; labeled "typical, unremarkable volume") and J3262 ranks #371 of 618 (40th percentile; labeled "typical, unremarkable volume"). These rankings suggest the provider is a median participant for abatacept and below‑median for tocilizumab relative to national peers, even though both still contribute meaningful revenue.

Evaluation-and-management activity supports ongoing patient management alongside infusion services: 99214 shows 426 claims and $36.2K in revenue (4.1% of Medicare revenue) and ranks #63066 of 479517 providers nationally (87th percentile; labeled "typical, unremarkable volume"). The above-average national percentile for 99214 indicates substantial office-based follow-up and chronic disease management for Medicare patients.

There are a few highly ranked, low-revenue outliers in diagnostic imaging use: 72202 (three or more X‑ray views of the sacroiliac joints) generates $1.3K (0.2% of revenue) but ranks #17 of 565 providers nationally (97th percentile; labeled "typical, unremarkable volume"). That combination — small absolute revenue but very high percentile ranking — signals the provider’s relative specialty in selected imaging studies compared with peers, even if the dollar impact is limited.

Provider tenure is long-standing: the NPI was enumerated on 2009-05-21 (~17 years ago), which aligns with a mature practice likely built around infusion-based rheumatology care. This duration, combined with the concentration in biologic administration, suggests an established operational model and patient panel focused on chronic inflammatory disease management.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	8,090	$30	$266.8K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	8,380	$30	$217.8K
J3262	Injection, tocilizumab, 1 mg	32,760	$10	$163.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	10,300	$10	$113.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	430	$90	$36.2K
J0897	Injection, denosumab, 1 mg	1,620	$20	$30.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	250	$100	$23.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	190	$50	$8.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	60	$100	$5.7K
73120	X–rays of the extremities have been performed to assess injury, fracture, arthritis, bone spurs, tumors, or congenital abnormalities. Extremity X–rays include the hand, wrist, arm, foot, ankle, hip,…	90	$40	$3.9K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Wisconsin Distribution

Paul Tuttle — 2 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Wisconsin

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	8	10	8,170	$30	$286.2K
J1602	9	10	11,900	$10	$206.3K
J3262	6	10	35,280	$1	$191.4K
J1745	4	20	6,060	$30	$168.9K
J0897	35	60	2,220	$20	$69.3K
96413	11	80	110	$90	$12.7K
99214	393	9,800	80	$70	$9.2K
96365	19	90	50	$50	$5.8K
99204	565	3,390	30	$100	$3.7K
36415	1,191	2,300	70	$10	$2.3K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Paul Tuttle, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bellin Memorial Hospital Inc	WI	Family Medicine Physician	$0	$19.8M
Oconto Hospital & Medical Center Inc	WI	Critical Access Hospital	$0	$4.8M
Oconto Hospital & Medical Center Inc	WI	Rural Health Clinic/Center	$0	$4.2M
Debbie Lim	WI	Rheumatology Physician	$1.8M	$0
Paul Utrie	WI	Rheumatology Physician	$1.3M	$0
Kevan Lewis	WI	MOHS-Micrographic Surgery Physician	$1.2M	$0
Riley Smyth	WI	Diagnostic Radiology Physician	$805.1K	$320
Michael Avery	WI	Rheumatology Physician	$681.6K	$0
James Lee	CA	Cardiovascular Disease Physician	$373.1K	$0
Aaron Gould	IL	Diagnostic Radiology Physician	$126.2K	$209.3K

Nearby Providers

Other providers in the same ZIP code as Paul Tuttle, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eric Lund	WI	Clinical Psychologist	$0	$77.1M
Baycare Aurora, LLC	WI	General Acute Care Hospital	$0	$25.4M
County Of Brown	WI	Clinic/Center	$0	$21.1M
Caravel Autism Health, LLC	WI	Behavior Analyst	$0	$18.5M
County Of Brown	WI	Community/Behavioral Health Agency	$0	$8.2M
Visiting Nurse Association Of Wisconsin, Inc.	WI	Home Infusion Therapy Pharmacy	$0	$5M
Baycare Clinic LLP	WI	Emergency Medicine Physician	$0	$3.6M
County Of Brown	WI	Case Management Agency	$0	$3.3M
Aegis Group Inc	WI	Land Ambulance	$1.2M	$1.6M
Visiting Nurse Association Of Wisconsin, Inc	WI	Home Health Agency	$0	$2.7M

Paul Tuttle — Billing Profile & Reimbursement Data

Sign up for Paul Tuttle — Billing Profile & Reimbursement Data policy alerts

Paul Tuttle — Billing Profile & Reimbursement Data

Sign up for Paul Tuttle — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References